Published in Immunol Res on January 01, 2008
Regulation of immune responses by mTOR. Annu Rev Immunol (2011) 3.08
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat Immunol (2011) 3.03
The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity (2010) 2.85
Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol (2011) 2.81
Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood (2009) 1.42
Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state. PLoS One (2012) 1.07
The role and regulation of mTOR in T-lymphocyte function. Arch Immunol Ther Exp (Warsz) (2012) 0.88
Runx3-mediated transcriptional program in cytotoxic lymphocytes. PLoS One (2013) 0.87
TGF-β sensitivity restrains CD8+ T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15. PLoS One (2012) 0.86
MHC-dependent desensitization of intrinsic anti-self reactivity. Cancer Immunol Immunother (2008) 0.83
Quieting T cells with Slfn2. Nat Immunol (2010) 0.81
Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis. PLoS One (2014) 0.77
Molecular and Cellular Characterization of Human CD8 T Suppressor Cells. Front Immunol (2016) 0.76
A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function. Retrovirology (2014) 0.75
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 16.46
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev (1994) 8.52
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 7.11
Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity (2000) 6.97
Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93
TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med (2005) 6.87
Anoikis mechanisms. Curr Opin Cell Biol (2001) 6.36
Differential requirements for survival and proliferation of CD8 naïve or memory T cells. Science (1997) 6.28
Persistence of memory CD8 T cells in MHC class I-deficient mice. Science (1999) 6.20
Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity (2006) 5.91
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J (1999) 5.49
Smads: transcriptional activators of TGF-beta responses. Cell (1998) 5.33
Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med (2000) 5.07
T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med (2005) 4.28
Impaired Fas response and autoimmunity in Pten+/- mice. Science (1999) 4.25
Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol (2004) 4.21
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity (2006) 4.06
Transcriptional mechanisms underlying lymphocyte tolerance. Cell (2002) 4.04
PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol (2003) 3.92
Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med (2001) 3.74
Homeostasis of memory T cells. Immunol Rev (2006) 3.69
Signals and signs for lymphocyte responses. Cell (1994) 3.66
T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest (2002) 3.41
Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci U S A (1999) 3.06
Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature (2004) 3.05
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med (1987) 3.03
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol (2001) 2.97
The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol (2006) 2.96
Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature (2002) 2.71
PTEN: from pathology to biology. Trends Cell Biol (2003) 2.69
Regulation of quiescence in lymphocytes. Trends Immunol (2003) 2.58
Cytokines and T-cell homeostasis. Curr Opin Immunol (2007) 2.58
An enhanced immune response in mice lacking the transcription factor NFAT1. Science (1996) 2.55
Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest (2003) 2.54
Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res (2002) 2.45
Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med (2000) 2.45
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood (2003) 2.31
A role for TCR affinity in regulating naive T cell homeostasis. J Immunol (2004) 2.09
Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc Natl Acad Sci U S A (2004) 2.08
Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene (1995) 2.05
The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev (2003) 2.02
IAN family critically regulates survival and development of T lymphocytes. PLoS Biol (2006) 1.95
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat Immunol (2006) 1.89
Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res (2002) 1.89
MHC class I is required for peripheral accumulation of CD8+ thymic emigrants. J Immunol (1998) 1.87
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration. Clin Cancer Res (2007) 1.86
Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc Natl Acad Sci U S A (1992) 1.83
Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A (1995) 1.81
Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity (2000) 1.79
NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell (2002) 1.79
Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med (2003) 1.71
The molecular program induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci U S A (2004) 1.66
Tetracycline-controllable selection of CD4(+) T cells: half-life and survival signals in the absence of major histocompatibility complex class II molecules. J Exp Med (2000) 1.61
An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J Exp Med (2007) 1.59
Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol Cell Biol (1999) 1.57
Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition. J Immunol (2003) 1.55
Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J Exp Med (2007) 1.54
Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection. J Immunol (2006) 1.51
T cell homeostasis in tolerance and immunity. J Leukoc Biol (2005) 1.50
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood (2007) 1.49
Survival of naive CD4 T cells: roles of restricting versus selecting MHC class II and cytokine milieu. J Immunol (1999) 1.42
Control of homeostatic proliferation by regulatory T cells. J Clin Invest (2005) 1.40
Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev (2002) 1.36
TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. J Immunol (2005) 1.35
Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis. Curr Biol (1999) 1.34
The lymphocyte guard-IANs: regulation of lymphocyte survival by IAN/GIMAP family proteins. Trends Immunol (2006) 1.34
Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells? J Exp Med (2003) 1.34
IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J Immunol (2007) 1.30
Protein kinase C-theta (PKCtheta): it's all about location, location, location. Immunol Rev (2003) 1.28
Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J Immunol (2004) 1.24
Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model. Immunity (2002) 1.22
CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med (2002) 1.22
p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness. J Immunol (2004) 1.19
Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice. Blood (2006) 1.19
Tob genes in development and homeostasis. Dev Dyn (2007) 1.17
Lymphocyte activation in health and disease. Crit Rev Immunol (1997) 1.17
MHC and T cell development. Rev Immunogenet (1999) 1.15
Nuclear localization of Tob is important for regulation of its antiproliferative activity. Oncogene (2004) 1.13
New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT. Curr Opin Immunol (2007) 1.12
TGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene (2005) 1.12
Massive and destructive T cell response to homeostatic cue in CD24-deficient lymphopenic hosts. J Exp Med (2006) 1.11
MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo. Proc Natl Acad Sci U S A (2007) 1.11
On the role of MHC class II molecules in the survival and lymphopenia-induced proliferation of peripheral CD4+ T cells. Proc Natl Acad Sci U S A (2003) 1.08
c-Myc acts downstream of IL-15 in the regulation of memory CD8 T-cell homeostasis. Blood (2006) 1.06
Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle. Mol Cancer Ther (2006) 1.05
Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3. J Immunol (2005) 1.05
Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function. J Immunol (2005) 1.05
Identification of the Anti-proliferative protein Tob as a MAPK substrate. J Biol Chem (2002) 1.04
Hierarchical control of lymphocyte survival. Science (1996) 1.04
CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack. Cancer Res (2007) 1.04
Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15. J Immunol (2001) 1.03
Antigen activation rescues recent thymic emigrants from programmed cell death in the BB rat. J Immunol (1998) 1.00
PI3K-signalling in B- and T-cells: insights from gene-targeted mice. Biochem Soc Trans (2003) 0.99
Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res (2006) 0.99
Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse. J Immunol (1999) 0.99
GIMAP5 regulates mitochondrial integrity from a distinct subcellular compartment. Biochem Biophys Res Commun (2007) 0.97
CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells. Int Immunopharmacol (2003) 0.95
The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med (2009) 2.82
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma. BMC Cancer (2010) 1.13
Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy. Cancer Res (2004) 0.96
Partial activation precedes apoptotic death in T cells harboring an IAN gene mutation. Eur J Immunol (2004) 0.90
Loss of a gimap/ian gene leads to activation of NF-kappaB through a MAPK-dependent pathway. Mol Immunol (2006) 0.88
Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells. Clin Immunol (2004) 0.88
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. PLoS One (2010) 0.87
Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer. Mol Ther (2012) 0.85
Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. J Pharmacol Exp Ther (2004) 0.84
MHC-dependent desensitization of intrinsic anti-self reactivity. Cancer Immunol Immunother (2008) 0.83
Enhancing antimelanoma immune responses through apoptosis. Cancer Gene Ther (2003) 0.83
Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer. Clin Chem (2013) 0.81
IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses. J Immunother (2012) 0.80
Animal models of type 1 diabetes: genetics and immunological function. Adv Exp Med Biol (2004) 0.75